[Treatment of essential arterial hypertension with spironolactone: its value in the detection of primary hyperaldosteronism and prediction of its efficacy].
D015065:17-Hydroxycorticosteroids / Q000652:urine; D015068:17-Ketosteroids / Q000652:urine; D000367:Age Factors; D000450:Aldosterone / Q000652:urine; D004035:Diet Therapy; D006801:Humans; D006929:Hyperaldosteronism / Q000175:diagnosis* / Q000652:urine; D006973:Hypertension / Q000188:drug therapy* / Q000652:urine; D011188:Potassium / Q000097:blood; D012964:Sodium / Q000097:blood / Q000627:therapeutic use; D013148:Spironolactone / Q000627:therapeutic use*; D013997:Time Factors
D015065:17-Hydroxycorticosteroids; D015068:17-Ketosteroids; D013148:Spironolactone; D000450:Aldosterone; D012964:Sodium; D011188:Potassium
Traitement de l'hypertension artérielle essentielle par la spironolactone: son intérêt dans le dépistage des hyperaldostéronismes primaires et prédiction de son efficacité.